Evaluation status available after sign-in
About the journal
Cell Reports Medicine is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 5,790 USD. Declared review time at DOAJ: 36 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-3791
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 5,790 USD
- Articles in DOAJ
- 843
- Declared review time
- 36 weeks
- Declared peer-review model
- other
- Official website
- https://www.sciencedirect.com/journal/cell-reports-medicine
Index listings
- DOAJ · 2020-10-29
- MEDLINE · 2020-01-01
- PUBMED · 2020-04-21
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 5,790 USD
- Declared review time (DOAJ)
- 36 weeks
- Actual review time (measured)
- 230 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
843
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
36weeks
Works in OpenAlex
2142
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
101
i10-index
1153
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2020-10-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 76%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101766894
Classification2
Subjects (DOAJ)
Medicine: Medicine (General)
LCC codes
R5-920
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- SARS-CoV-2 and COVID-19 Research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Show all subjects (75)
- CAR-T cell therapy research
- CAR-T cell therapy research
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Gut microbiota and health
- Gut microbiota and health
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Gut microbiota and health
- COVID-19 Clinical Research Studies
- Immune cells in cancer
- CAR-T cell therapy research
- Immune cells in cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Single-cell and spatial transcriptomics
- Monoclonal and Polyclonal Antibodies Research
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- Ferroptosis and cancer prognosis
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Virus-based gene therapy research
- Ferroptosis and cancer prognosis
- Immune cells in cancer
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- vaccines and immunoinformatics approaches
- Cancer Cells and Metastasis
- Artificial Intelligence in Healthcare and Education
- Cancer Research and Treatments
- Immune responses and vaccinations
- Lung Cancer Treatments and Mutations
- Cancer Research and Treatments
- Glioma Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Glioma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Breast Cancer Treatment Studies
- Diet and metabolism studies
- Diet and metabolism studies
- Cancer, Hypoxia, and Metabolism
- CRISPR and Genetic Engineering
- interferon and immune responses
- Epigenetics and DNA Methylation
- Cancer, Hypoxia, and Metabolism
- Radiomics and Machine Learning in Medical Imaging
- Cancer, Hypoxia, and Metabolism
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Cancer Research and Treatments
- interferon and immune responses
- HIV Research and Treatment
Keywords (DOAJ)
- medicine
- clinical medicine
- translational medicine
- disease
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ